Erratum to lncRNA NFYC-AS1 promotes the development of lung adenocarcinomas through autophagy, apoptosis, and MET/c-Myc oncogenic proteins
Editorial Office
DOI: https://doi.org/10.21037/atm-2024-6
IF: 3.616
2024-10-19
Annals of Translational Medicine
Abstract:Editorial Office Annals of Translational Medicine Submitted May 14, 2024. Accepted for publication May 23, 2024. Published online Jul 05, 2024. doi: 10.21037/atm-2024-6 Erratum to: Ann Transl Med 2021;9:1621. This article (1) titled "LncRNA NFYC-AS1 promotes the development of lung adenocarcinomas through autophagy, apoptosis, and MET/c-Myc oncogenic proteins" (doi: 10.21037/atm-21-4995), unfortunately contains an error in the Funding section. The Funding 'Guangzhou Science and Technology Plan Project (Grant No. 202102021238 to FN)' should be added to the Funding section. The updated Funding section is presented below. The authors apologize for the oversight. Click here to view the updated version of the article. Funding: This work was supported in part by National Natural Science Foundation of China (NSFC) (Grant No. 81702270 to FN, 81802335 to YS), Affiliated Hospital of Guangzhou Medical University Foundation (Grant No. 2013A41 to JD), Clinical Key Specialty Construction Project of Guangzhou Medical University (Grant No. YYPT202017), and Guangzhou Science and Technology Plan Project (Grant No. 202102021238 to FN). Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
oncology,medicine, research & experimental